Advertisement
RCEL vs STXS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCEL is a Buy and STXS is a Buy.
Aroon Indicator for RCEL shows an upward move is likely
RCEL's Aroon Indicator triggered a bullish signal on November 11, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 178 similar instances where the Aroon Indicator showed a similar pattern. In 155 of the 178 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 87%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on RCEL as a result. In 78 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for RCEL just turned positive on November 09, 2026. Looking at past instances where RCEL's MACD turned positive, the stock continued to rise in 43 of 51 cases over the following month. The odds of a continued upward trend are 84%.
Following a +6.39% 3-day Advance, the price is estimated to grow further. Considering data from situations where RCEL advanced for three days, in 221 of 280 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
Bearish Trend Analysis
The 10-day RSI Indicator for RCEL moved out of overbought territory on November 11, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 28 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCEL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
RCEL broke above its upper Bollinger Band on November 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: RCEL's P/B Ratio (-18.431) is slightly lower than the industry average of (4.142). P/E Ratio (-11.521) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (4.136) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. RCEL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RCEL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
STXS's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for STXS turned positive on November 05, 2026. Looking at past instances where STXS's MACD turned positive, the stock continued to rise in 44 of 52 cases over the following month. The odds of a continued upward trend are 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where STXS's RSI Indicator exited the oversold zone, 24 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
Following a +8.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where STXS advanced for three days, in 152 of 205 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
STXS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 50 cases where STXS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 88%.
The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on STXS as a result. In 79 of 104 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where STXS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Aroon Indicator for STXS entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 80 (best 1 - 100 worst), indicating slightly worse than average price growth. STXS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.921) is normal, around the industry mean (4.964). P/E Ratio (-4.542) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (12.600) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (4.248) is also within normal values, averaging (56.876).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STXS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
RCEL | STXS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 87 | 10 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 16 Undervalued | 94 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 34 | 80 | |
P/E GROWTH RATING 1..100 | 98 | 15 | |
SEASONALITY SCORE 1..100 | 50 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RCEL's Valuation (16) in the null industry is significantly better than the same rating for STXS (94) in the Medical Specialties industry. This means that RCEL’s stock grew significantly faster than STXS’s over the last 12 months.
RCEL's Profit vs Risk Rating (100) in the null industry is in the same range as STXS (100) in the Medical Specialties industry. This means that RCEL’s stock grew similarly to STXS’s over the last 12 months.
RCEL's SMR Rating (100) in the null industry is in the same range as STXS (100) in the Medical Specialties industry. This means that RCEL’s stock grew similarly to STXS’s over the last 12 months.
RCEL's Price Growth Rating (34) in the null industry is somewhat better than the same rating for STXS (80) in the Medical Specialties industry. This means that RCEL’s stock grew somewhat faster than STXS’s over the last 12 months.
STXS's P/E Growth Rating (15) in the Medical Specialties industry is significantly better than the same rating for RCEL (98) in the null industry. This means that STXS’s stock grew significantly faster than RCEL’s over the last 12 months.
| RCEL | STXS | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 77% |
| Stochastic ODDS (%) | 1 day ago 84% | 1 day ago 88% |
| Momentum ODDS (%) | 1 day ago 80% | 1 day ago 76% |
| MACD ODDS (%) | 1 day ago 84% | 1 day ago 85% |
| TrendWeek ODDS (%) | 1 day ago 83% | 1 day ago 83% |
| TrendMonth ODDS (%) | 1 day ago 85% | 1 day ago 84% |
| Advances ODDS (%) | 2 days ago 79% | 3 days ago 74% |
| Declines ODDS (%) | 9 days ago 80% | 1 day ago 82% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 72% |
| Aroon ODDS (%) | 1 day ago 87% | 1 day ago 86% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
RCEL’s FA Score shows that 1 FA rating(s) are green while STXS’s FA Score has 1 green FA rating(s).
- RCEL’s FA Score: 1 green, 4 red.
- STXS’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
RCEL’s TA Score shows that 4 TA indicator(s) are bullish while STXS’s TA Score has 5 bullish TA indicator(s).
- RCEL’s TA Score: 4 bullish, 4 bearish.
- STXS’s TA Score: 5 bullish, 3 bearish.
Price Growth
RCEL (@Medical/Nursing Services) experienced а +15.13% price change this week, while STXS (@Pharmaceuticals: Other) price change was +22.18% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.96%. For the same industry, the average monthly price growth was +6.35%, and the average quarterly price growth was +22.73%.
Reported Earning Dates
RCEL is expected to report earnings on Feb 25, 2027.
STXS is expected to report earnings on Feb 26, 2027.
Industries' Descriptions
@Medical/Nursing Services (-2.89% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (+1.96% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
Advertisement
RCEL and
Correlation & Price change
A.I.dvisor indicates that over the last year, RCEL has been loosely correlated with SENS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RCEL jumps, then SENS could also see price increases.
| Ticker / NAME | Correlation To RCEL | 1D Price Change % | ||
|---|---|---|---|---|
| RCEL | 100% | -1.98% | ||
| SENS - RCEL | 45% Loosely correlated | +3.89% | ||
| NTRA - RCEL | 30% Poorly correlated | +2.51% | ||
| VCYT - RCEL | 29% Poorly correlated | +4.36% | ||
| TWST - RCEL | 29% Poorly correlated | -7.22% | ||
| STXS - RCEL | 29% Poorly correlated | -12.62% | ||
More | ||||
STXS and
Correlation & Price change
A.I.dvisor indicates that over the last year, STXS has been loosely correlated with SMTI. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if STXS jumps, then SMTI could also see price increases.
| Ticker / NAME | Correlation To STXS | 1D Price Change % | ||
|---|---|---|---|---|
| STXS | 100% | -12.62% | ||
| SMTI - STXS | 38% Loosely correlated | -0.16% | ||
| TWST - STXS | 36% Loosely correlated | -7.22% | ||
| CERS - STXS | 35% Loosely correlated | +8.72% | ||
| VCYT - STXS | 33% Poorly correlated | +4.36% | ||
| SHC - STXS | 32% Poorly correlated | +1.04% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| QEW | 29.16 | 0.63 | +2.22% |
| Invesco QQQ Equal Weight ETF (QEW) | |||
| AIEQ | 48.71 | 0.60 | +1.26% |
| Amplify AI Powered Equity ETF (AIEQ) | |||
| KLMN | 30.79 | N/A | N/A |
| Invesco MSCI North America Climate ETF | |||
| IBTP | 24.45 | -0.03 | -0.12% |
| iShares iBonds Dec 2034 Term Treasury ETF (IBTP) | |||
| MVAL | 41.29 | -0.16 | -0.39% |
| VanEck Morningstar Wide Moat Value ETF (MVAL) | |||